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Summary
Injury models have suggested that the lung contains
anatomically and functionally distinct epithelial stem
cell populations. We have isolated such a regional
pulmonary stem cell population, termed bronchioal-
veolar stem cells (BASCs). Identified at the bronchi-
oalveolar duct junction, BASCs were resistant to
bronchiolar and alveolar damage and proliferated
during epithelial cell renewal in vivo. BASCs exhib-
ited self-renewal and were multipotent in clonal as-
says, highlighting their stem cell properties. Further-
more, BASCs expanded in response to oncogenic
K-ras in culture and in precursors of lung tumors in
vivo. These data support the hypothesis that BASCs
are a stem cell population that maintains the bronchi-
olar Clara cells and alveolar cells of the distal lung
and that their transformed counterparts give rise to
adenocarcinoma. Although bronchiolar cells and al-
veolar cells are proposed to be the precursor cells of
adenocarcinoma, this work points to BASCs as the
putative cells of origin for this subtype of lung cancer.
Introduction
The pulmonary system contains a variety of epithelial
cell populations that each reside in distinct anatomical
locations. Basal, secretory, and ciliated cells line the
trachea and the proximal conducting airways; neuroen-
docrine cells are present in small numbers. The noncili-
ated, columnar Clara cells comprise the majority of the
bronchiolar and terminal bronchiolar epithelium in
mice, and alveolar type I (AT1) and type II (AT2) cells
constitute the alveolar epithelium (Bannister, 1999).
Injury models have suggested that functionally dis-
tinct epithelial stem cell populations exist in precise an-
atomical locations in the lung (Otto, 2002). A putative
tracheal and proximal conducting airway stem cell
niche has been identified by resistance to the detergent
polidocanol and sulfur dioxide (Borthwick et al., 2001).
Bleomycin administration results in AT1 cell injury, and
it has been proposed that AT2 cells repair the damaged*Correspondence: tjacks@mit.edu
3 Present address: Department of Neurological Surgery, University
of California, San Francisco, San Francisco, California 94143.
4 Present address: Department of Biomedical Sciences, Tufts Uni-
versity Veterinary School, North Grafton, Massachusetts 05136.alveolar epithelium (Aso et al., 1976). Naphthalene, a
pollutant that specifically ablates Clara cells, has been
used to identify two distinct stem cell niches. In proxi-
mal airways, naphthalene-resistant Clara cells are closely
associated with neuroendocrine bodies, whereas resis-
tant cells are found at the junction between the con-
ducting and respiratory epithelium (the bronchioal-
veolar duct junction, or BADJ) in terminal bronchioles
(TBs) (Giangreco et al., 2002; Hong et al., 2001; Rey-
nolds et al., 2000a; Reynolds et al., 2000b). “Side pop-
ulation” cells exhibiting Hoechst dye efflux properties
similar to those of hematopoietic stem cells have been
isolated from lung (Giangreco et al., 2003; Goodell et
al., 1996; Summer et al., 2003). Despite these ad-
vances, methods to isolate cells from putative stem cell
niches in the lung and functional tests for such popula-
tions have not been reported.
Just as our understanding of lung stem cell biology
is limited, the identity of the cell of origin in lung tumori-
genesis is also largely unknown. This is due in part to
the predominantly advanced stage of disease in most
patients at the time of diagnosis (Minna et al., 2002).
Interestingly, many of the subtypes of non-small cell
lung carcinoma share characteristics with differentiated
cells found in the distinct locations in which the tumors
arise. For example, squamous cell carcinomas exhibit
keratinization like mature epithelial cells in the trachea
and proximal airways and generally arise in bronchi,
whereas most adenocarcinomas display Clara or AT2
cell markers and are generally peripheral or endo-
bronchial (Rosai and Sobin, 1995). However, whether
the cancers arise from these differentiated cell com-
partments or from stem or progenitor cells has not
been established.
We previously developed a “Lox-Stop-Lox” K-ras
conditional mouse strain (referred to as LSL-K-ras
G12D), in which expression of oncogenic K-ras is spa-
tially and temporally controlled by a removable tran-
scriptional termination (“stop”) element (Jackson et al.,
2001). Intranasal infection with recombinant adenoviral
Cre (AdCre) results in deletion of the stop element, pro-
ducing the Lox-K-ras allele that expresses K-ras G12D.
Lox-K-ras mice develop atypical adenomatous hyper-
plasias (AAH; hyperproliferations of AT2 cells) that ap-
pear to progress to adenomas and then overt adeno-
carcinomas (Jackson et al., 2001). This progression,
together with the observation that Lox-K-ras adenocar-
cinomas were positive for the AT2 cell-specific marker
prosurfactant apoprotein-C (SP-C), was consistent with
previous studies that implicated AT2 cells as the target
cells in rodent and human lung adenocarcinomas.
However, evidence in other murine models and human
specimens points to Clara cells as the cell of origin of
adenocarcinoma (Dermer, 1982; Gunning et al., 1991;
Mason et al., 2000; Mori et al., 1993; Mori et al., 2001;
Thaete and Malkinson, 1991; Wikenheiser et al., 1992).
During analysis of Lox-K-ras tumors, we identified a
novel cell type, termed double-positive cells (DPCs).
DPCs expressing both SP-C and the Clara cell-specific
marker CCA (also known as CC10 or CCSP) were found
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Dbronchiolar hyperplasia (Jackson et al., 2001). We now
show that counterparts of the SP-Cpos CCApos Lox-K- s
ras DPCs, renamed BASCs, exist in normal lung, func-
tion in lung homeostasis, and possess characteristics B
Iof regional stem cells. Furthermore, we provide evi-






in Normal Adult Lung a
DPCs were initially observed in small clusters in Lox-K-
ras lung tumors, representing a small proportion of the I
ptotal tumor cell population that largely consisted of SP-
Cpos cells (Jackson et al., 2001). We reasoned that tu- c
tmor DPCs might originate from a cell population in the
adult lung similar to embryonic lung epithelial precur- c
dsors that are positive for Clara and AT2 cell markers
(Wuenschell et al., 1996). Therefore, sections of wild- i
mtype lung were examined by dual immunofluorescence
(IF) for CCA and SP-C. As shown in Figure 1, DPCs were (
cidentified in normal lung at the BADJ. As expected, CCA
staining was present in columnar bronchiolar and ter- B
tminal bronchiolar cells, whereas SP-C staining was lim-
ited to AT2 cells and DPCs. Upon examination of more s
3than 100 terminal bronchioles from five wild-type mice,
at least one DPC was detected in 35% ± 9% of BADJs. c
cNotably, CCA staining appeared to be less abundant in
DPCs than in Clara cells. DPCs were not identified in p
salveolar spaces, bronchioles, large airways, or in the
trachea. Rarely, DPCs were found in the proximal por- e
ntion of the terminal bronchiole (data not shown). Stain-
ing for the neuroendocrine cell marker CGRP was not c
observed at the BADJ (data not shown). Because theFigure 1. Identification of BASCs in Normal
Lung
BASCs (arrows) are located at the bronchi-
oalveolar duct junction (BADJ, brackets), the
branch point between a terminal bronchiole
(TB) lined with Clara cells positive for CCA
and the alveolar space (AS) lined with alveo-
lar epithelium including AT2 cells positive for
SP-C. IF for DAPI (blue), CCA (red), and
SP-C (green) is shown.
(A) 400× image, merge.
(B–D) Zoom of 400× image to highlight the
BADJ region. Merge (B), green channel only
(C), and red channel only (D). Scale bars,
10 m.data described below provide evidence that DPCsunction as stem cells for Clara cells and alveolar cells,
PCs will be referred to hereafter as bronchioalveolar
tem cells (BASCs).
ASCs Respond to Bronchiolar and Alveolar Injury
dentification of BASCs at the BADJ localized them in a
utative stem cell niche. Previous studies showed that
aphthalene-resistant Clara cells were present at the
ADJ. Furthermore, the BrdUpos CCApos cells identified
uring early airway renewal were located precisely
here we identified BASCs (Giangreco et al., 2002;
ong et al., 2001; Reynolds et al., 2000a; Reynolds et
l., 2000b).
To determine if airway damage affected BASCs, dual
F for CCA and SP-C was performed at various time
oints after naphthalene treatment. Although signifi-
ant Clara cell loss was observed by 52 hr after naph-
halene treatment, the number of BASCs did not signifi-
antly decrease at any time point (Figures 2A–2C and
ata not shown). The naphthalene-resistant population
ncluded BASCs and Clara cells. However, in some ter-
inal bronchioles, the only cells remaining were BASCs
data not shown). IF revealed that there was a signifi-
ant increase in terminal bronchioles with two or more
ASCs one week after naphthalene (16% ± 5% in con-
rols to 30% ± 9% at 1 week, p = 0.03; Figure 2C). Con-
istent with IF, FACS analysis (described below; Figure
) showed that the abundance of BASCs did not
hange 24 hr after naphthalene but was 1.3-fold in-
reased by 1 week after treatment (p = 0.04) (see Sup-
lemental Data available with this article online). Six to
even weeks after naphthalene treatment, bronchiolar
pithelium was restored (Giangreco et al., 2002; data
ot shown), and the number of BASCs per BADJ was
omparable to that in untreated lung (Figure 2C).
We administered BrdU prior to euthanasia to deter-mine if BASCs proliferated in response to naphthalene.
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(A and B) IF as in Figure 1, showing a TB from a naphthalene (A) or mock (B) treated mouse 36 hr after treatment. Arrows, BASCs. Asterisks,
Clara cells sloughing off into the airway. Inset, enlarged BADJ region. All scale bars, 10 m.
(C) The percentage of TBs containing 0, 1, and 2 or more BASCs at various time points after naphthalene is shown (mean ± SD).
(D) Four-color IF was performed to analyze proliferation after naphthalene treatment. DAPI staining (not shown) was used to identify the
outline of TBs (dashed line). A TB 52 hr after naphthalene is shown with a single BrdUpos (blue), SP-Cpos (green), CCApos (red) BASC at the
BADJ (arrow). Arrowheads point to a BrdUneg Clara cell more proximal in the TB (left) and a BrdUneg BASC at the other BADJ (right). Asterisk,
green autofluorescence.
(E) Staining as in (D) of a TB 72 hr after naphthalene shows BrdUneg BASCs at the BADJ (arrowheads) situated next to BrdUpos CCApos SP-
Cneg cells (arrows). Asterisks, cells sloughing off into the airway.
(F) The percentage of BrdUpos cells at the BADJ contributed by SP-Cpos CCApos cells (BASCs) or SP-Cneg CCApos cells (Clara cells) at various
time points after naphthalene treatment is shown. Data are from at least 100 BrdU-positive cells for each time point.
(G) The percentage of TBs containing 0, 1, and 2 or more BASCs (mean ± SD) at various time points after bleomycin is shown.In the BADJ, BrdUpos cells were first detected at 52 hr
after naphthalene, and all were SP-Cpos CCApos (Fig-
ures 2D and 2F). Seventy-two hours after naphthalene,
CCApos SP-Cneg BrdUpos cells were present adjacent to
BrdUneg BASCs (Figures 2E and 2F), suggesting that
they arose from BASCs. BrdUpos cells in the nonter-
minal bronchiolar epithelium at all time points were
CCApos SP-Cneg, consistent with the report of distinct
stem cell niches in proximal and terminal bronchioles
(Giangreco et al., 2002). BASCs were BrdUneg in normal,untreated lung (data not shown), whereas they prolifer-
ated during airway repair and were BrdUneg after its
completion.
Since these data pointed to a role for BASCs in ter-
minal bronchiolar cell maintenance, we next deter-
mined whether BASCs were also important in response
to alveolar damage. Bleomycin was administered intra-
nasally, and at various time points after treatment, the
incidence of BASCs was determined. Similar to their
response to naphthalene, BASC numbers increased af-
Cell
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(A) Typical scatter plot showing the distinct cellular populations in lung identified by staining for Sca-1, CD45, and Pecam. The percentage
of total lung represented by each population is indicated. Histograms show the percentage of cells positive for CD34 in a negative control
(no CD34 antibody) (top) and in the Sca-1pos CD45neg Pecamneg population (bottom).
(B) IF (as in other figures) of the indicated populations for CCA and SP-C after sorting and cytospin. The percentage of cells exhibiting the
representative staining pattern is 100% unless otherwise indicated. autoflhi, cells with high green autofluorescence without Sca-1 staining.
Scale bar, 10 m.ter bleomycin treatment. Significant increases were ob- c
mserved 14 days after bleomycin (p = 0.01), when AT1
cell depletion became evident in previous studies (Aso c
tet al., 1976). In contrast, BASC distribution was signifi-
cantly different neither at 7 days after treatment, before g
rsubstantial alveolar damage was documented, nor af-
ter 28 days, when effective repair is complete or long- e
term damage is apparent (Aso et al., 1976; Figure 2G).
Together, these data suggested that BASCs play a o




Based on their staining for AT2 and Clara cell-specific w
pmarkers, their response to damage in vivo, and their
location at the bifurcation between bronchiolar and res- o
wpiratory epithelium, we hypothesized that BASCs con-
stitute a stem or progenitor cell population that main- F
mtains Clara cells and AT2 cells in adult lung. To explorethis hypothesis, it was necessary to isolate and furtherharacterize BASCs. As CCA and SP-C are cytoplas-
ic, intracellular markers, they were not suitable for live
ell isolation of BASCs by FACS. Due to its presence on
he surface of hematopoietic stem cells and mammary-
land progenitors (Morrison and Weissman, 1994 and
eferences within; Welm et al., 2002), Sca-1 was consid-
red to be a potential marker of BASCs.
We developed the following protocol for purification
f BASCs by FACS. Fresh lung cells were prepared, red
lood cells were removed by lysis, and the hematopoi-
tic and endothelial lineages were excluded by virtue
f the fact that they are positive for CD45 and Pecam,
espectively. From the remaining cells, Sca-1pos cells
ere sorted to determine if they contained the BASC
opulation (Figure 3). This population represented 0.4%
f the total lung cell preparation in 4- to 8-week-old
ild-type mice (Figure 3A). Immunophenotyping of the
ACS-sorted populations using the CCA and SP-C
arkers determined that only the Sca-1pos CD45negPecamneg population contained BASCs (Figure 3B).
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cells, whereas 15% were CCApos ciliated cells. The
Sca-1neg CD45neg Pecamneg population with high au-
tofluorescence was comprised of SP-Cpos CCAneg AT2
cells and represented 5%–20% of the total lung popula-
tion. The Sca-1neg CD45neg Pecamneg population with
low autofluorescence contained CCApos Clara cells and
other unidentified cells. The Sca-1neg CD45pos Pec-
ampos population was composed of hematopoietic
cells, including macrophages. The Sca-1pos CD45pos
Pecampos population contained mostly endothelial
cells, and 10% was composed of highly autofluores-
cent, Pecamneg Sca-1neg AT2 cells (data not shown).
BASCs were purified further based on positive stain-
ing for CD34, a known marker of skin epithelial and
hematopoietic stem cells, (Blanpain et al., 2004; Ra-
malho-Santos et al., 2002; Ivanova et al., 2002; Tumbar
et al., 2004; Morris et al., 2004). Two to sixteen percent
of Sca-1pos CD45neg Pecamneg cells were positive for
CD34 (Figure 3A). Whereas the Sca-1pos CD45neg Pec-
amneg CD34neg population contained ciliated cells and
CCApos SP-Cpos cells (data not shown), all cells in the
Sca-1pos CD45neg Pecamneg CD34pos population were
positive for CCA and SP-C, and no ciliated cells were
present (Figure 3B). Thus, the Sca-1pos CD45neg Pec-
amneg CD34pos population was further enriched for
BASCs.
To verify the anatomical location of the cells selected
using this FACS isolation scheme, we performed IF for
CCA, Sca-1, and CD34 on lung tissue sections. Sca-1
and CD34 were detected in endothelial cells in capillar-
ies and larger blood vessels. All Sca-1pos cells in
bronchioles were CD34neg ciliated cells, whereas Sca-
1pos cells in terminal bronchioles were at the BADJ and
were CCApos (Supplemental Data and data not shown).
CD34 staining was detected in some Clara cells in
bronchioles (Supplemental Data). Importantly, Sca-1pos
CD34pos CCApos cells were located exclusively at the
BADJ (Supplemental Data). To determine if these cells
were of hematopoietic origin, sections were also
stained for the marker CD45. The CD34pos cells were
negative for CD45 (Supplemental Data). These data
suggested that use of Sca-1- and CD34-positive sur-
face staining, together with exclusion of hematopoietic
and endothelial lineage, allows for the isolation of the
same BADJ cells identified by IF for CCA and SP-C.
Together, these results provided a FACS methodology
sufficient to isolate live lung cell populations and com-
pare their ability to self-renew and differentiate in
culture.
BASCs Exhibit Stem Cell Properties in Culture
Lung epithelial cells harvested using this FACS protocol
formed colonies after 1 week when grown on feeders
(Figure 4A). All cells in feeder-grown colonies from
BASC cultures were CCApos SP-Cpos, suggesting that
growth on feeders maintained the cells’ undifferenti-
ated state. Eighty percent of colonies on feeders from
total lung cultures also contained CCApos SP-Cpos cells,
but in all colonies examined, these cells were only a
portion of the colony. The remainder of total lung colo-
nies contained CCAneg SP-Cpos cells. Thus, the colo-
nies present in total lung cultures likely arose from amixture of AT2 cells, BASCs, and other unidentified
cells, an important note for subsequent analyses of to-
tal lung cultures. As expected, AT2 cultures only con-
tained SP-Cpos cells (Supplemental Data).
Several methods were used to show that the colonies
arising from BASC cultures were clonal. First, 5% of
single-cell cultures of Sca-1pos CD45neg Pecamneg
CD34 pos cells plated on feeders formed epithelial colo-
nies identical to those arising from multiple Sca-1pos
CD45neg Pecamneg cells (Figure 4A). Plating of neither
single AT2 cells nor single total lung cells produced col-
onies. Second, limiting dilution analysis revealed that
the BASC population is 5.5-fold enriched for single
cells that can give rise to colonies. There was a linear
relationship between the cell density and the number
of colonies generated from total lung or BASCs but not
those generated from AT2 cells (Figure 4B). Limiting di-
lution showed that 1 out of 452 total lung cells gave
rise to a colony, whereas the clonal frequency was 1
out of 81 for the Sca-1pos CD45neg Pecamneg popula-
tion. Finally, plating mixtures of GFPpos BASCs from D4/
XEGFP mice, which carry an X-linked GFP transgene
(Hadjantonakis et al., 1998), with GFPneg BASCs from
wild-type mice only yielded entirely GFPpos or GFPneg
colonies (Supplemental Data). In contrast, mixtures of
GFPpos and GFPneg AT2 cells and total lung cells pro-
duced mixed colonies (containing GFPpos and GFPneg
cells), suggesting that the majority of their colonies
were not clonal; these data are consistent with IF and
limiting dilution results (Supplemental Data).
In addition to clonal colony formation, only BASCs
exhibited extensive self-renewal in culture (Figure 4C).
Single-cell suspensions from individual colonies in pri-
mary total lung and BASC cultures formed colonies
identical to primary cell colonies (Figure 4A and data
not shown), whereas AT2 cultures did not produce sec-
ondary colonies. Total lung cell cultures failed to pro-
duce colonies in tertiary cultures, perhaps owing to the
use of nonclonal colonies (above). In contrast, the Sca-
1pos CD45neg Pecamneg population has been passaged
up to nine times to date without diminution of colony-
forming ability (Figure 4C and data not shown).
BASCs also had a greater capacity for differentiation
than other lung epithelial cells (Figure 4D). By 4 days
on Matrigel, Sca-1pos CD45neg Pecamneg cells formed
three-dimensional structures containing a central clus-
ter ofw400 cells with surrounding cells exhibiting short
cytoplasmic extensions. By 7 days, the cytoplasmic ex-
tensions were more complex and resembled alveolar
epithelium. Total lung cell cultures produced similar
structures, whereas AT2 cultures remained in small
clusters. Furthermore, Sca-1pos CD45neg Pecamneg
CD34pos BASC cultures appeared identical to those
isolated without CD34 selection (compare images in
Figure 4D).
Immunophenotyping of Matrigel cell cultures with
CCA, SP-C, and aquaporin-5 (AQ5), a marker of AT1
cells (Nielsen et al., 1997), confirmed the multilineage
differentiation capacity of BASCs. Seven- to ten-day-
old total lung cell and BASC cultures contained CCApos
SP-Cneg cells (Clara-like cells), SP-Cpos CCAneg cells
(AT2-like cells), and AQ5pos cells (AT1-like cells) (Figure
4). Cells with the most abundant SP-C staining were
located around the periphery of the cell clusters in
Cell
828Figure 4. BASCs Self-Renew and Are Multipotent
(A) Phase-contrast images of colonies resulting from (left to right) feeder-cultured BASCs, secondary BASC culture, a single Sca-1pos CD45neg
Pecamneg CD34pos cell plated on day 0, and its resulting colony after 1 week.
(B) Limiting dilution analysis comparing AT2 cells, total unsorted lung, and BASCs. The percentage of wells without colony formation for the
corresponding number of plated cells is shown with the coefficient and formula from regression analysis. Data from three independent
experiments (mean ± SD) were used.
(C) Limiting dilution analysis of serially passaged cells.
(D) Representative phase-contrast images of Matrigel-cultured Sca-1pos CD45neg Pecamneg cells (S+45−P−), total lung, AT2 cells, and Sca-
1pos CD45neg Pecamneg CD34pos cells (S+45−P−34+).
(E–T) Cultures grown on Matrigel were subjected to IF for SP-C (green) and CCA (red) (E, G, I, K, M–T) or SP-C (green) and AQ5 (red) (F, H, J,
L) and analyzed by deconvolution microscopy to assess differentiation. All scale bars, 10 m. Images represent similar results from at least
three independent experiments.
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(see Figure 2). LSL-K-ras G12D mice and wild-type con-to three BASCs with or without AdCre (Figures 5A and
(E–L) BASC cultures contained SP-Cpos CCAneg cells (arrows in [E] and [G], enlarged in [I] and [K]), AQ5pos cells (arrows in [F], enlarged in
[J]), and SP-Cneg CCApos cells (arrowheads in [G], enlarged in [K]). Only SP-Cpos cells were present in AT2 cell cultures ([H], enlarged in [L]).
(M–P) Differentiated cells derived from a single Sca-1pos CD45neg Pecamneg CD34pos cell were SP-Cpos CCAneg (arrows) (M and O) or SP-Cneg
CCApos cells (arrowheads) (N and P). Cells in (M) and (N) were derived from a single cell, and cells in (O) and (P) were derived from another
single cell.
(Q–T) Single cells on the periphery of clusters derived from fifth (Q and R) or eighth (S and T) passage BASCs were SP-Cpos CCAneg (arrows)BASC cultures (Figures 4E and 4I). The cells extending
from the core cluster and exhibiting cytoplasmic
branching reminiscent of AT1 cells were AQ5pos, as
were rare cells on the periphery of the clusters (Figures
4F and 4J). Dissociation of the clusters revealed that
they contained Clara-like and AT2-like cells (Figures 4G
and 4K). FACS further confirmed the differentiation
status of cells in Matrigel cultures (Supplemental Data).
BASC cultures contained AT2 cells (25%–84% of the
culture), Clara/other unidentified cells (28%–70%), and
BASCs (0.36%–3.3%). Total lung cultures consisted of
Clara/other unidentified cells, AT2 cells, and endothelial
cells but no BASCs. AT2 cell cultures retained the AT2
cell population and did not produce BASCs.
In our analyses, 100% of BASC cultures were multi-
potent, producing Clara- and AT2-like cells. In contrast,
25% of total lung cultures were multipotent, 50% pro-
duced AT2-like cells only, and 25% produced Clara-like
cells only. AT2 cell cultures did not exhibit differentia-
tion (Figures 4H and 4L). Importantly, 100% of colonies
derived from single BASCs gave rise to both Clara- and
AT2-like cells on Matrigel (n = 6, representing three in-
dependent experiments) (Figures 4M–4P). Furthermore,
even after eight passages, BASC clones produced
Clara- and AT2-like cells, showing that they retained
differentiation capacity while undergoing self-renewal
(Figures 4Q–4T). No ciliated cells were detected at any
time point of culturing based on morphology and stain-
ing with antisera raised against acetylated tubulin (data
not shown), suggesting that ciliated cells present in the
sorted Sca-1pos CD45neg Pecamneg population (Figure
3) did not survive culture conditions or contribute to
differentiation and other culture characteristics.
Together, data from lung cell cultures demonstrated
that BASCs are able to self-renew and possess multilin-
eage differentiation potential.
BASCs Are Expanded in Lung Tumorigenesis
Identification of BASCs at the BADJ placed them at a
putative site of tumorigenesis, supporting the hypothe-
sis that BASCs may be important in lung adenocarci-
noma initiation. Serial section analysis indicated that
Lox-K-ras adenomas often arose near terminal bronchi-
oles. In fact, lesions present at early time points after
oncogenic K-ras activation appeared to be continua-
tions of bronchiolar hyperplasia and alveolar hyperpla-
sia arising in terminal bronchioles (Jackson et al., 2001).
Supporting their role in tumorigenesis, IF showed
that BASC numbers were increased in the earliest tu-
morigenic lesions in Lox-K-ras mice. Whereas the ma-
jority of wild-type terminal bronchioles contained one(Q and T) or SP-Cneg CCApos cells (arrowheads) (R and S).5C), up to four BASCs at a single BADJ were detected
1 week after AdCre in 2% of Lox-K-ras terminal
bronchioles (Figures 5B and 5C). The distribution of
BASCs continued to increase 2 weeks after AdCre;
seven BASCs were observed at single BADJs, and 16%
of TBs had four to seven BASCs (p = 1.7e−6 compared
to wild-type controls) (Figure 5C). Verifying IF results, a
3.6-fold increase in BASCs in Lox-K-ras mice was ob-
served by FACS analysis 5 days after AdCre administra-
tion (p = 0.009) (Supplemental Data). These data show
that BASC expansion was coincident with the forma-
tion of AAH, the precursor lesion for adenocarcinoma
(Jackson et al., 2001). Furthermore, delivery of in-
creased titer of AdCre, which resulted in increased tu-
mor number (Jackson et al., 2001), was also correlated
to an increase in BASC incidence (p = 1.7e−12; Figure
5D), linking BASC expansion to tumor number. BASC
numbers further increased during tumor progression;
37% of Lox-K-ras terminal bronchioles had four to eight
BASCs 6 weeks after Cre (p = 5.4e−6; Figure 5C) and
BASCs were also expanded 12 weeks after Cre (p =
1.3e−6; Figure 5E).
Consistent with BASC expansion being a key, early
event in tumorigenesis, we observed a specific effect
of K-ras G12D activation on the proliferation and differ-
entiation of BASCs. LSL-K-ras G12D BASC cultures
treated with AdCre underwent a 2.5-fold expansion in
cell number compared to control cultures (p = 0.05; Fig-
ure 6A). In contrast, AdCre-infected AT2 cultures did
not show a significant change in cell number. AdCre-
infected BASC cultures exhibited reduced differentia-
tion; the percentage of Matrigel-grown BASC cultures
composed of Sca-1pos CD45neg Pecamneg cells was
4-fold increased compared to AdEmpty-infected cul-
tures, there was a 1.6-fold increase in AT2 cells, and a
decrease in other cells was observed (Figure 6B). These
findings were similar to the changes in abundance of
BASCs and AT2 cells observed by FACS after K-ras
G12D activation in vivo (Supplemental Data). Impor-
tantly, BASCs did not arise in AdCre-treated AT2 cell
cultures. Our observations were not due to inherent dif-
ferences in ability to infect BASC and AT2 cell cultures,
as they exhibited similar efficiency for recombination of
the K-ras allele (Figure 6C). These data suggested that
the first outcome of K-ras G12D activation on lung epi-
thelia is an expansion of BASC number and subsequent
differentiation toward the alveolar lineage.
BASC Stimulation In Vivo Affects Tumorigenesis
We reasoned that we could further dissect the cellular
requirements for adenocarcinoma formation by com-
bining K-ras G12D activation with naphthalene treat-
Cell
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All bar graphs show mean ± SD.
(A and B) IF for CCA and SP-C as in other figures, from wild-type (A) and Lox-K-ras (B) mice 1 week after AdCre. Expanded numbers of
BASCs (arrows) are observed in Lox-K-ras lung. Images, 400×; scale bars, 10 m.
(C) Distribution of BASC number at time points indicated after AdCre. The percentage of TBs containing one to eight BASCs is shown for
wild-type (+/+, left) and Lox-K-ras (K/+, right) lungs.
(D) The percentage of Lox-K-ras TBs with at least one BASC detected for each AdCre dose (particle-forming units/ml).
(E) The percentage of TBs with at least one BASC in Lox-K-ras mice (K/+) compared to wild-type mice (+/+) is shown for each condition.trols were treated with naphthalene, tumorigenesis was s
iinitiated by administering AdCre 24 hr to 3 days later,
and mice were euthanized after 6 weeks to determine v
tumor incidence and size.
Naphthalene administration resulted in an increase in D
tumor number and area, further implicating BASCs in
tumor initiation. In three independent experiments, W
lnaphthalene treatment was correlated with an increase
in tumor number; 1.3-, 2.2-, and 2.3-fold more tumors l
pwere observed in Lox-K-ras mice treated with naphtha-
lene before AdCre compared to controls (p = 0.04; Fig- r
ture 7A). An even greater impact on tumor area was as-
sociated with naphthalene treatment; adenomas B
lcomprised a 6-, 12-, and 15-fold greater proportion of
total lung area when initiated after airway damage in K
sthe three experiments (p = 0.009; Figure 7B). Impor-
tantly, increased tumorigenicity was not attributable to l
Bmore effective AT2 cell infection after naphthalene
treatment. Infection with AdGFP followed by IF for i
SP-C or CCA 24 hr later indicated that there was noignificant increase in the incidence of GFPpos AT2 cells
n control versus naphthalene-treated animals (7.8%
ersus 10.5% of infected cells were SP-Cpos).
iscussion
e have identified a cell population in the adult mouse
ung that has properties of stem cells and is linked to
ung tumor initiation. Wild-type BASCs were found in a
utative stem cell niche, proliferated during epithelial
epair in vivo, and were capable of multipotent differen-
iation and self-renewal in culture. We suggest that
ASCs are a regional stem cell population in the distal
ung. Increases in BASC number were observed in Lox-
-ras mice with AAH and adenomas. The temporal and
patial correlation of BASC expansion with early-stage
esions suggests that AAH arise from transformed
ASCs. Stimulation of BASCs by airway injury resulted
n an increase in tumor number and size, further impli-
cating BASCs in tumorigenesis.
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vation
(A) The fold change in the number of cells (mean ± SD) present
after culture and infection with Adeno Empty (AdE) or Adeno Cre
(AdCre) is shown for LSL-K-ras G12D BASC and AT2 cell cultures.
Cell number was determined by FACS.
(B) The fold change in the percentage of the total population
(AdCre/AdE) represented by BASCs, AT2 cells, and Clara/uniden-
tified cells, determined by FACS (mean ± SD).
(C) PCR to assess recombination in infected BASC or AT2 cell cul-
tures. wt, product amplified from wild-type allele; one-lox, product
from recombined Lox-K-ras allele; + control, DNA from a Lox-K-
ras tumor.ing increasingly important to define precise criteria forFigure 7. Cooperation between Naphthalene Treatment and K-ras
Tumorigenesis In Vivo
Tumor number (A) and tumor area (B) (calculated as the ratio of
tumor area to lung area) in Lox-K-ras mice (K/+) after treatment
with naphthalene prior to infection (Nap Ad Cre), compared to con-
trols treated with corn oil only (Oil Ad Cre), are shown. Data are the
mean ± SD from one of three independent experiments that had
similar results.Defining Lung Stem Cells
Our data illustrate that BASCs are bona fide stem cells
that share characteristics with previously defined adult
stem cell populations (Blanpain et al., 2004; Chiasson
et al., 1999; Doetsch et al., 1999; Johansson et al.,
1999; Kruger et al., 2002; Morris et al., 2004; Tropepe
et al., 2000). Importantly, we have shown that cultured
BASCs exhibit proliferative capacity and self-renewal
and are multipotent in clonal assays. BASCs have re-
tained these properties over eight passages to date.
As studies identifying populations with stem cell
properties from solid adult tissues emerge, it is becom-stem cell terminology. For example, it is currently de-
bated whether an essential part of the definition of a
stem cell is the ability to reconstitute the majority of a
tissue upon reintroduction in vivo or if it is sufficient
to demonstrate comparable properties in cell culture.
Ascribing stem cell characteristics to a cell population
without evidence for differentiation and self-renewal in
vivo may weaken the term “stem cells” (Seaberg and
van der Kooy, 2003), but, in fact, rather few reports of
stem cell populations have been supported by in vivo
data. Furthermore, some studies that include in vivo
data have relied on expansion of putative stem cells in
culture prior to engraftment, raising the possibility that
culturing changed the potency of the isolated cell pop-
ulation (Blanpain et al., 2004; Gage et al., 1995; Span-
grude et al., 1995).
We acknowledge that the ultimate test for stem cell
activity is a single-cell clonogenic transplantation as-
say, as has been done in the hematopoietic system
(Krause et al., 2001; Osawa et al., 1996). However, such
assays are particularly challenging when applied to
stem cells of epithelial tissues. Epithelial cells are
closely associated with endothelial cells, stromal fibro-
blasts, inflammatory cells, and accompanying extracel-
Cell
832lular matrix and cell-cell interactions. Some or all of a
these components may be required to allow survival, 2
engraftment, and proper differentiation of putative stem c
and progenitor cells. Although there is an established w
protocol to test for mammary epithelial stem cells with- s
out injection of additional exogenous supporting cells t
(Deome et al., 1959; Hoshino and Gardner, 1967; Welm c
et al., 2002), a comparable system remains to be cre- t
ated for other epithelial tissues, including the lung. b
It will be crucial to formally determine the ability of t
BASCs to produce differentiated lung epithelia and self- p
renew in vivo to further define their functions. It remains c
possible that BASCs may function more similarly to p
progenitor cells, rather than stem cells, in an in vivo p
setting; further, the BASC population we isolated may d
contain a mixture of stem and progenitor cells. Al-
though there is an assay for reconstitution of denuded E
trachea subcutaneously implanted into immunode- O
ficient mice, this system provides a tracheal-like envi- t
ronment rather than mimicking the distal lung region w
(Delplanque et al., 2000). Bone-marrow cells may con- v
tribute to lung tissue after damage (Harris et al., 2004; t
Kotton et al., 2001; Krause et al., 2001), but it is unlikely n
that stem cells normally residing in the lung can survive P
conditions in circulation and home properly to the p
BADJ. Therefore, experiments to test stem cell function e
of BASCs may require introduction precisely to their G
original niche. This will likely involve introduction of ge- B
netically marked BASCs into the respiratory system of s
wild-type mice after bronchiolar or alveolar cell dam- (
age. Alternatively, it would be informative to genetically o
label endogenous BASCs or other epithelial cells speci- o
fically in vivo after lung damage and track their progeny i
without introduction of exogenous cells. Such studies m
would define the lineage relationships that exist be- c
tween adult lung epithelial cells but will require addi-
i




Current evidence supports the existence of multiple
gstem cell niches in the lung (Otto, 2002). Our work sug-
bgests that BASCs are a stem cell population for distal
lung epithelia with potentiality limited to Clara, AT2, and
sAT1 cells. Their location in the BADJ places BASCs
cnext to each of the niches in which their putative prog-
eeny reside (the terminal bronchiole for Clara cells and
gthe alveolar space for AT2 cells). Furthermore, BASCs
sare normally in a quiescent state and can be activated
tin response to bronchiolar and alveolar injury in vivo.
rThe expansion of BASCs during airway renewal was
csubtle, leading us to hypothesize that BASCs give rise
Bto a progenitor population, perhaps a subtype of Clara
Fcells, that restores damaged terminal bronchiolar epi-
wthelium. BASCs were the first cells to proliferate in re-
psponse to naphthalene, and they comprised the major-
tity of the proliferating population up to 1 week after
tdamage. BrdUpos Clara cells were situated next to
BBrdUneg BASCs at later stages of terminal bronchiolar
prepair, consistent with the hypothesis that they arose
cfrom BASCs.
fBASCs may also give rise to an alveolar progenitor
bpopulation to maintain alveolar homeostasis in vivo,
lgiven their response to bleomycin treatment. Although
the commonly held view has been that AT2 cells are
progenitors for AT1 cells because cultured AT2 cellscquire AT1-like properties in culture (Isakson et al.,
001), our data suggest that BASCs give rise to AT1
ells. Alternatively, BASCs may give rise to AT2 cells,
hich, in turn, produce AT1 cells. Interestingly, the re-
ults of Aso et al. suggest that there may be two niches
hat mediate alveolar repair; both proliferation of AT2
ells in alveolar spaces and expansion and differen-
iation of some bronchiolar cells was observed after
leomycin-mediated damage (Aso et al., 1976). Fur-
hermore, Daly et al. found that SP-C and CC10 coex-
ression was present in a subset of distal bronchiolar
ells following bleomycin-mediated lung injury and pro-
osed that this finding may be evidence for a stem cell
opulation in bronchioles that responds to alveolar
amage nearby (Daly et al., 1997; Daly et al., 1998).
lucidating Lung Cancer Cells of Origin
ur work provides the first evidence that stem cells are
he target cell population in lung adenocarcinoma. Prior
ork from Dick, Weissman, and colleagues has pro-
ided compelling evidence that stem cells can be the
arget cells in tumorigenesis for hematopoietic malig-
ancies (Bonnet and Dick, 1997; Cozzio et al., 2003;
assegue et al., 2004). Importantly, BASCs were ex-
anded at early stages of tumorigenesis in vivo and
xhibited the first proliferative response following K-ras
12D activation in culture. We have also observed
ASC expansion in association with lung tumorigene-
is initiated by expression of a point mutant p53 allele
Olive et al., 2004), ruling out a specific effect of AdCre
n BASC expansion (data not shown). Since Clara cells
r AT2 cells are widely thought to be the precursor cells
n adenocarcinoma, this work points to an alternative
odel of the cell of origin for this subtype of lung can-
er. Although we found expanded numbers of BASCs
n early lesions, we have not yet shown that BASCs are
ecessary for tumor development and maintenance. It
s conceivable that a progenitor cell population that
ains the property of self-renewal may be equally capa-
le of supporting tumor initiation (Cozzio et al., 2003).
We hypothesize that lung tumors arise from expan-
ion of stem cells and that advanced tumors retain
haracteristics of differentiated lineage(s) due to influ-
nces from the microenvironment or continued onco-
enic signaling. For example, expansion of BASCs
timulated by oncogenic K-ras and continued prolifera-
ion in the context of constitutive K-ras signaling may
esult in adenocarcinomas largely composed of AT2
ells. Our analysis of the effect of activated K-ras on
ASC differentiation in culture supports this reasoning.
urther, we found that most cells in Lox-K-ras tumors
ere SP-Cpos CCAneg, and some tumor cells were also
ositive for AQ5 (Jackson et al., 2001; data not shown);
he immunophenotype of Lox-K-ras tumors matches
he alveolar differentiation pattern we observed for
ASCs. It is likely that a corresponding human BASC
opulation exists, and it too may play a role in adeno-
arcinoma development. This would account for the
act that adenocarcinomas most frequently resemble
ronchiolar and alveolar components of normal human
ung (Rosai and Sobin, 1995).
Identification of the BASC population, its niche, anda means to isolate and propagate this population lends
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833promise to a better understanding of the cellular and
molecular mechanisms of lung development, homeo-
stasis, and disease. Chronic lung diseases could theo-
retically be alleviated by directed differentiation of lung
stem cells to restore defective lung epithelia. These
cells may also be used for ex vivo gene therapy of ge-
netic diseases affecting the lung such as cystic fibrosis.
Regarding lung cancer, BASCs were detected in estab-
lished tumors, suggesting that they may contribute
continuously to tumor development and progression.
Tumor-associated BASCs may constitute a tumor stem
cell population similar to those that have been defined
in breast and brain cancers (Al-Hajj et al., 2003; Reya
et al., 2001; Singh et al., 2003; Singh et al., 2004) and,
as such, may be a critical target for anticancer therapy.
Finally, additional studies pointing to a role for BASCs
in tumor initiation may fuel more effective early-identifi-
cation markers and chemoprevention strategies for
lung cancer by specifically targeting hyperproliferative
BASCs in the early stage of disease.
Experimental Procedures
Mice and Tissues
Lox-stop-lox K-ras G12D mice (Jackson et al., 2001) and wild-type
littermates were maintained in viral-free conditions on an F1 129
SvJ/C57Bl6 background. Four- to eight-week-old mice were used
for FACS or intranasal infections as described (Jackson et al.,
2001). Naphthalene (Aldrich) was dissolved in Mazola corn oil and
injected i.p. at 275 mg/kg using sex- and background-matched
control mice. Bleomycin (Sigma; 40 l of 1.88 U/ml in PBS) was
administered intranasally. 30 mg/kg BrdU in PBS was injected i.p.
2 hr before euthanasia for proliferation studies. Tissue preparation
was as described (Jackson et al., 2001). BASCs were quantified by
scoring sections from at least three mice for each condition. Bio-
quant Software was used to quantify tumor area.
FACS Analysis
Single-cell suspensions from lung were prepared as described with
modifications (Bortnick et al., 2003; see also Supplemental Data).
Sca-1-FITC, CD45.1-Biotin, Pecam-Biotin, CD34-PE, and Streptavi-
din-PE were from Pharmingen. 7AAD (Molecular Probes) staining
eliminated dead cells. Cell sorting was performed with a Cytoma-
tion MoFlo, and data were analyzed with Cytomation Summit
software.
Immunofluorescence
Immunostaining of tissues and cells was performed as previously
described (Jackson et al., 2001) using antisera raised against
mouse CCA (gift); proSP-C (RDI); proSP-C clone 7705, CC10, CD34
clone C-18, and aquaporin 5 (Santa Cruz); proSP-C (Chemicon
clone 3786); CGRP and acetylated tubulin (Sigma); CD34 Mec14.7
(Abcam); Sca-1 (R&D Systems); BrdU (Becton Dickinson); and don-
key Alexafluore secondary antibodies (Molecular Probes). Sorted
or cultured cells were stained after cytospin at 600 rpm for 3 min
and fixation and permeabilization with CytoFix/CytoPerm (Phar-
mingen). Triple-color microscopy and imaging were performed with
a Nikon Eclipse E600 and a Spot cooled CCD camera and software.
Four-color microscopy and deconvolution were performed with a
Zeiss Axioplan II, cooled CCD camera, and OpenLab software.
Images were processed with Adobe Photoshop.
Epithelial Cultures
Cells were plated in DME/HEPES/10% FBS on 96-well plates
coated with 100 l Matrigel (Becton Dickinson) or irradiated DR4
MEFs. Matrigel cultures were fixed on plates or treated with colla-
genase/dispase for cytospin, IF, and FACS. For limiting dilution
analysis, 1, 10, 100, or 1000 cells were sorted onto feeders to as-
sess colony formation 1 week later. Regression analysis was per-
formed to calculate the x value at which the y value is 37%, whichcorrelates with each colony arising from a single cell (Tropepe et
al., 2000). For serial passage, wells containing a single colony were
trypsinized, and single cell suspensions were plated onto fresh
feeder-coated wells for the next passage. Colony number was as-
sessed after 1 week, and the process was repeated. Matrigel cul-
tures were infected with 1e6 PFU AdCre or AdEmpty after 1–3 days
in culture and analyzed by FACS 7 days later.
Statistics
Statistical analyses were performed using Mstat software (Norman
Drinkwater, McArdle Laboratory for Cancer Research, University of
Wisconsin). For comparison of the distribution of BASC number
per terminal bronchiole, the Cochran-Armitage test was performed,
and data with a trend p value of 0.05 or less were considered signif-
icant. Other analyses were done using the Wilcoxon rank sum test
or Fisher’s exact test as appropriate.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and five figures and are available with this article online at http://
www.cell.com/cgi/content/full/121/6/823/DC1/.
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